Accessibility Menu
 
Teleflex logo

Teleflex

(NYSE) TFX

Current Price$116.27
Market Cap$5.14B
Since IPO (1968)+76,028%
5 Year-71%
1 Year-16%
1 Month+4%

Teleflex Financials at a Glance

Market Cap

$5.14B

Revenue (TTM)

$2.96B

Net Income (TTM)

$905.64M

EPS (TTM)

$-20.56

P/E Ratio

-5.65

Dividend

$1.36

Beta (Volatility)

0.87 (Low)

Price

$116.27

Volume

56,452

Open

$114.17

Previous Close

$116.27

Daily Range

$114.08 - $116.95

52-Week Range

$100.18 - $141.91

TFX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Teleflex

Industry

Healthcare Equipment and Supplies

Employees

15,500

CEO

Liam J. Kelly, PhD

Headquarters

Wayne, PA 19087-1603, US

TFX Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

10%

Net Income Margin

-31%

Return on Equity

-5%

Return on Capital

5%

Return on Assets

-13%

Earnings Yield

-17.70%

Dividend Yield

0.01%

Payout Ratio

-6.65%

Stock Overview

Market Cap

$5.14B

Shares Outstanding

44.20M

Volume

56.45K

Short Interest

0.00%

Avg. Volume

963.79K

Financials (TTM)

Gross Profit

$1.12B

Operating Income

$255.80M

EBITDA

$302.51M

Operating Cash Flow

$340.68M

Capital Expenditure

$95.24M

Free Cash Flow

$245.44M

Cash & ST Invst.

$393.26M

Total Debt

$2.73B

Teleflex Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$568.98M

-28.5%

Gross Profit

$307.45M

-30.1%

Gross Margin

54.03%

N/A

Market Cap

$5.14B

N/A

Market Cap/Employee

$364.33K

N/A

Employees

14,100

N/A

Net Income

$714.33M

-422.7%

EBITDA

$15.73M

+143.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.33B

-59.2%

Accounts Receivable

$345.58M

-24.8%

Inventory

$404.39M

-32.6%

Long Term Debt

$2.63B

+58.6%

Short Term Debt

$100.00M

+0.0%

Return on Assets

-13.04%

N/A

Return on Invested Capital

4.65%

N/A

Free Cash Flow

$151.56M

-11.1%

Operating Cash Flow

$152.21M

-24.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TGTXTG Therapeutics, Inc.
$31.75-0.72%
ALKSAlkermes plc
$29.39-1.77%
BLCOBausch + Lomb Corporation
$15.37-3.27%
PTCTPTC Therapeutics, Inc.
$66.13-1.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About TFX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.